Establishment, characterization, and differentiation of a karyotypically normal human embryonic stem cell line from a trisomy-affected embryo

  • Arundhati Mandal
  • Sheena Mathew
  • Debapriya Saha
  • Chandra Viswanathan


Derivation of human embryonic stem cell (hESC) lines from chromosomally or genetically abnormal embryos obtained following preimplantation genetic diagnosis (PGD) is of immense interest to study various kinds of genetic disorders. In this study, we have established a new hESC line Relicell®hES4, isolated from an aneuploid embryo. Derivation of this cell line was achieved by isolation of the inner cell mass (ICM) by mechanical method. Karyotype analysis showed that the hESC line is euploid having 46 chromosomes, contrary to our expectations. The undifferentiated cells exhibited long-term proliferation capacity and expressed markers typical for hESC, such as OCT4, NANOG, and SSEA4. A comparative microarray study was carried out to analyze the transcription profile of Relicell®hES4 along with three other normal hESC line generated earlier in our lab. Relicell®hES4 manifested pluripotent differentiation potential both in vivo and in vitro. The cells were also induced to form neurons, cardiomyocytes, and pancreatic β islets. The generation of a normal hESC line from an abnormal embryo points to the fact that even such embryos can be considered for deriving new hESC lines instead of discarding them. The data represented here are the first detailed report on characterization and differentiation of an Indian hESC line generated from a PGD analyzed embryo.


Preimplantation genetic diagnosis Human ES cell line Characterization of human ES cells Microarray Differentiation of human ES cells 

Supplementary material

11626_2012_9567_MOESM1_ESM.docx (13 kb)
Supplementary Table 1Antibodies details used for immunofluorescence staining (DOCX 12 kb)


  1. Abeyta M. J.; Clark A. T.; Rodriguez R. T.; Bodnar M. S.; Pera R. A.; Firpo M. T. Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum. Mol. Genet. 13(6): 601–608; 2004.PubMedCrossRefGoogle Scholar
  2. Amit M.; Carpenter M. K.; Inokuma M. S.; Chiu C. P.; Harris C. P.; Waknitz M. A.; Itskovitz-Eldor J.; Thomson J. A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227(2): 271–278; 2000.PubMedCrossRefGoogle Scholar
  3. Baart E. B.; Martini E.; van den Berg I.; Macklon N. S.; Galjaard R. J.; Fauser B. C.; Van Opstal D. Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Hum. Reprod. 21(1): 223–233; 2006.PubMedCrossRefGoogle Scholar
  4. Biancotti J. C.; Narwani K.; Buehler N.; Mandefro B.; Golan-Lev T.; Yanuka O.; Clark A.; Hill D.; Benvenisty N.; Lavon N. Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells 28(9): 1530–1540; 2010.PubMedCrossRefGoogle Scholar
  5. Choo A. B.; Churchill G. A.; Corbel M.; Damjanov I.; Draper J. S.; Dvorak P.; Emanuelsson K.; Fleck R. A.; Ford A.; et al. Characterization of human embryonic stem cell lines by the international stem cell initiative. Nat. Biotech. 25: 803–816; 2007.CrossRefGoogle Scholar
  6. Colman A.; Dreesen O. Pluripotent stem cells and disease modeling. Cell Stem Cell 5(3): 244–247; 2009.PubMedCrossRefGoogle Scholar
  7. Dvash T.; Benvenisty N. Human embryonic stem cells as a model for early human development. Best Pract Res Clin Obstet Gynaecol. 18(6): 929–940; 2004.PubMedCrossRefGoogle Scholar
  8. Eiges R.; Urbach A.; Malcov M.; Frumkin T.; Schwartz T.; Amit A.; Yaron Y.; Eden A.; Yanuka O.; Benvenisty N.; Ben-Yosef D. Developmental study of Fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1(5): 568–577; 2007.PubMedCrossRefGoogle Scholar
  9. Gardner D. K.; Lane M.; Stevens J.; Schlenker T.; Schoolcraft W. B. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil. Sterl. 73: 1155–1158; 2000.CrossRefGoogle Scholar
  10. Gavrilov S.; Prosser R. W.; Khalid I.; MacDonald J.; Sauer M. V.; Landry D. W.; Papaioannou V. E. Non-viable human embryos as a source of viable cells for embryonic stem cell derivation. Reprod. Biomed. Online 18(2): 301–308; 2009.PubMedCrossRefGoogle Scholar
  11. Harper J. C.; Pergament E.; Delhanty J. D. Genetics of gametes and embryos. Eur. J. Obstet. Gynecol. Reprod. Biol. 115(suppl 1): S80–S84; 2004.PubMedCrossRefGoogle Scholar
  12. Iacovitti L.; Donaldson A. E.; Marshall C. E.; Suon S.; Yang M. A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: studies in vitro and in vivo. Brain Res. 1127(1): 19–25; 2007.PubMedCrossRefGoogle Scholar
  13. Jiang J.; Au M.; Lu K.; Eshpeter A.; Korbutt G.; Fisk G.; Majumdar A. S. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25(8): 1940–1953; 2007.PubMedCrossRefGoogle Scholar
  14. Klimanskaya I.; Chung Y.; Becker S.; Lu S. J.; Lanza R. Derivation of human embryonic stem cells from single blastomeres. Nat. Protoc. 2(8): 1963–1972; 2007.PubMedCrossRefGoogle Scholar
  15. Krey L. C.; Grifo J. A. Poor embryo quality: the answer lies (mostly) in the egg. Fertil. Steril. 75: 466–468; 2001.PubMedCrossRefGoogle Scholar
  16. Lavon N.; Narwani K.; Golan-Lev T.; Buehler N.; Hill D.; Benvenisty N. Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells 26(7): 1874–1882; 2008.PubMedCrossRefGoogle Scholar
  17. Liu Y.; Shin S.; Zeng X.; Zhan M.; Gonzalez R.; Mueller F.; Schwartz C. M.; Xue H.; Li H.; Baker S. C.; Chudin E.; Barker D.; McDaniel T. K.; Oeser S.; Loring J. F.; Mattson M. P.; Rao M. S. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev. Biol. 6: 20; 2006.PubMedCrossRefGoogle Scholar
  18. Mai Q.; Yu Y.; Li T.; Wang L.; Chen M.; Huang S.; Zhou C.; Zhou Q. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res. 17(12): 1008–1019; 2007.PubMedCrossRefGoogle Scholar
  19. Mandal A.; Bhowmik S.; Patki A.; Viswanathan C.; Majumdar A. S. Derivation, characterization, and gene expression profile of two new human ES cell lines from India. Stem Cell. Res. 5(3): 173–187; 2010.PubMedCrossRefGoogle Scholar
  20. Mandal A.; Tipnis S.; Pal R.; Ravindran G.; Bose B.; Patki A.; Rao M. R. Characterization and in vitro differentiation potential of a new human embryonic stem cell line, ReliCell®hES1. Differentiation 74(2–3): 81–90; 2006.PubMedCrossRefGoogle Scholar
  21. Mateizel I.; De Temmerman N.; Ullmann U.; Cauffman G.; Sermon K.; Van de Velde H.; De Rycke M.; Degreef E.; Devroey P.; Liebaers I.; Van Steirteghem A. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum. Reprod. 21(2): 503–511; 2006.PubMedCrossRefGoogle Scholar
  22. Mitalipova M.; Calhoun J.; Shin S.; Wininger D.; Schulz T.; Noggle S.; Venable A.; Lyons I.; Robins A.; Stice S. Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21(5): 521–526; 2003.PubMedCrossRefGoogle Scholar
  23. Munne S.; Cohen J. Chromosome abnormalities in human embryos. Hum. Reprod. Update 4(6): 842–855; 1998.PubMedCrossRefGoogle Scholar
  24. Munné S.; Velilla E.; Colls P.; Bermudez M.; Vemuri M.; Steuerwald N.; Garrisi J.; Cohen J. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fertil. Steril. 84: 1328–1334; 2005.PubMedCrossRefGoogle Scholar
  25. Narwani K.; Biancotti J. C.; Golan-Lev T.; Buehler N.; Hill D.; Shifman S.; Benvenisty N.; Lavon N. Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In Vitro Cell. Dev. Biol. Anim. 46(3–4): 309–316; 2010. 2010 Epub 2010 Mar 12.PubMedCrossRefGoogle Scholar
  26. Peura T.; Bosman A.; Chami O.; Jansen R. P.; Texlova K.; Stojanov T. Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos. Clon. Stem Cell. 10(2): 203–216; 2008.CrossRefGoogle Scholar
  27. Pickering S. J.; Minger S. L.; Patel M.; Taylor H.; Black C.; Burns C. J.; Ekonomou A.; Braude P. R. Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation ΔF508, using preimplantation genetic diagnosis. Reprod. Biomed. Online 10(3): 390–397; 2005.PubMedCrossRefGoogle Scholar
  28. Skottman H.; Mikkola M.; Lundin K.; Olsson C.; Strömber A. M.; Tuuri T.; Otonkoski T.; Hovatta O.; Lahesmaa R. Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells 23: 1343–1356; 2005.PubMedCrossRefGoogle Scholar
  29. Thomson J. A.; Itskovitz-Eldor J.; Shapiro S. S.; Waknitz M. A.; Swiergiel J. J.; Marshall V. S.; Jones J. M. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147; 1998.PubMedCrossRefGoogle Scholar
  30. Verlinsky Y.; Strelchenko N.; Kukharenko V.; Rechitsky S.; Verlinsky O.; Galat V.; Kuliev A. Human embryonic stem cell lines with genetic disorders. Reprod. Biomed. Online 10(1): 105–110; 2005.PubMedCrossRefGoogle Scholar
  31. Wilton L. Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat. Diagn. 22: 512–518; 2002.PubMedCrossRefGoogle Scholar
  32. Zeng X.; Miura T.; Luo Y.; Bhattacharya B.; Condie B.; Chen J.; Ginis I.; Lyons I.; Mejido J.; Puri R. K.; Rao M. S.; Freed W. J. Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells 22: 293–312; 2004.Google Scholar
  33. Zhang J.; Wilson G. F.; Soerens A. G.; Koonce C. H.; Yu J.; Palecek S. P.; Thomson J. A.; Kamp T. J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104: e30–e41; 2009.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for In Vitro Biology 2012

Authors and Affiliations

  • Arundhati Mandal
    • 1
  • Sheena Mathew
    • 1
  • Debapriya Saha
    • 1
  • Chandra Viswanathan
    • 1
  1. 1.Regenerative Medicine, Reliance Life Sciences Pvt LtdDhirubhai Ambani Life Sciences CentreNavi MumbaiIndia

Personalised recommendations